Quality by design tool-evaluated stability-indicating ultra-performance liquid chromatography method for the determination of drugs (ritonavir and darunavir) used to treat the human immunodeficiency virus/acquired immunodeficiency syndrome.
QbD
UPLC
darunavir
factorial design
ritonavir
Journal
Biomedical chromatography : BMC
ISSN: 1099-0801
Titre abrégé: Biomed Chromatogr
Pays: England
ID NLM: 8610241
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
revised:
22
04
2023
received:
20
03
2023
accepted:
31
05
2023
medline:
16
8
2023
pubmed:
1
7
2023
entrez:
1
7
2023
Statut:
ppublish
Résumé
Ritonavir and darunavir were examined using a ultra-performance liquid chromatography (UPLC) approach in pharmaceutical dosage forms. The small number of analytical studies that are currently available do not demonstrate the method's stability or nature. The study sought to assess both chemicals using a stability-indicating approach with a relatively short run time. The HSS C
Substances chimiques
Darunavir
YO603Y8113
Ritonavir
O3J8G9O825
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e5687Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Abduljalil, K., & Badhan, R. K. (2016). Drug dosing during pregnancy-Opportunities for physiologically based pharmacokinetic models. Clinical Pharmacokinetics, 55, 381-396. https://doi.org/10.1007/s40262-015-0325-8
Chiranjeevi, K., & Channabasavaraj, K. P. (2011). Development and validation of RP-HPLC method for quantitative estimation of ritonavir in bulk and pharmaceutical dosage forms. International Journal of Pharmaceutical Sciences and Research, 2, 596.
Dandabattina, R., Subramanian, V. B., Merugu, K. S., SharathBabu, H., Katari, N. K., & Kowtharapu, L. P. (2023). Stability-indicating RP-HPLC method development and validation for Eltrombopag Olamine in the presence of impurities and degradation products. Robustness by Design of Expert Software. Journal of AOAC International, 106, 267-275. https://doi.org/10.1093/jaoacint/qsac153
Ettaboina, S. K., Katakam, L. N. R., & Dongala, T. (2022). Development and validation of a stability-indicating RP-HPLC method for the determination of erythromycin related impurities in topical dosage form. The Pharmaceutical Journal, 56, 131-113. https://doi.org/10.1007/s11094-022-02610-5
Grace, P. L., & Parthiban, C. (2022). Analytical method development and validation for the simultaneous estimation of Darunavir and ritonavir by RP-HPLC method. World Journal of Pharmaceutical Research, 10, 32-40. https://doi.org/10.54037/WJPS.2022.100103
International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, (2005). Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology. International Conference on Harmonization (ICH).
Jagadeeswaran, M., Gopal, N., Kumar, K. P., & Kumar, T. S. (2012). Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method. Pharmceutica Analytica Acta, 3, 3-5.
Jythesh Kumar, S. R., Vandavasi, K. R., Katari, N. K., Jyothi Narreddy, S., & Kowtharapu, L. P. (2023). Determination and quantification of related substances and degradation products in Bictegravir by full factorial design evaluated HPLC and mass spectrometry. Analytical Methods, 2023, 1274-1285. https://doi.org/10.1039/D2AY02106D
Kashish, G., Nisha, P., & Hiren, K. (2020). Analytical techniques in the analysis of darunavir and ritonavir: A review. Current Pharmaceutical Analysis, 16, 447-455. https://doi.org/10.2174/1573412915666190206124808
Kavitha, A. N. (2020). A new validated RP-HPLC method for the estimation of Darunavir Ethanolate in bulk and tablets. Asian. Journal of Pharmaceutics, 14. https://doi.org/10.22377/ajp.v14i4.3834
Konduru, N., Gundla, R., Dongala, T., Katari, N. K., & Mallavarapu, R. (2022). Development and validation of liquid chromatography method for determination of Ibrutinib in finished dosage forms using quality by design approach. Journal of Seperation Science Plus, 5, 254-266. https://doi.org/10.1002/sscp.202100063
Kowtharapu, L. P., Katari, N. K., Muchakayala, S. K., Pydimarry, S. P., Rekulapally, V. K., & Sandoval, C. A. (2023). QbD green analytical procedure for novel study of a genotoxic and carcinogenic compound trace determination in physiological solution compatibility. Sustainable Chemistry and Pharmacy, 33, 101079. https://doi.org/10.1016/j.scp.2023.101079
Kowtharapu, L. P., Katari, N. K., Sandoval, C. A., Rekulapally, V. K., & Jonnalagadda, S. B. (2022). Green chromatographic method for determination of active pharmaceutical ingredient, preservative, and antioxidant in an injectable formulation: Robustness by design expert. ACS Omega, 7, 34098-34108. https://doi.org/10.1021/acsomega.2c03387
Kumar, M. S., Rani, B. S., Mounika, N., Mamatha, J., & Kumar, J. K. (2016). A validated RP-HPLC method for the simultaneous estimation of Atazanavir and ritonavir in pharmaceutical dosage forms. ARC Journal of Pharmaceutical Sciences, 2, 21-31.
Lathouwers, E., De Meyer, S., Dierynck, I., Van de Casteele, T., Lavreys, L., de Béthune, M. P., & Picchio, G. (2011). Virological characterization of patients failing darunavir/ritonavir orlopinavir/ritonavir treatment in the ARTEMIS study: 96-week analysis. Antiviral Therapy, 16, 99-108. https://doi.org/10.3851/IMP17
Masaaki, T., Yuichi, K., Naoya, O., Atsushi, H., Kazuhide, B., & Tsuguhiro, K. (2021). The validation of plasma Darunavir concentrations determined by the HPLC method for protease inhibitors. Biological & Pharmaceutical Bulletin, 30, 1947-1949. https://doi.org/10.1248/bpb.30.1947
Mishra, T., & Shrivastav, P. S. (2014). Validation of simultaneous quantitative method of HIV protease inhibitors Atazanavir, Darunavir and ritonavir in human plasma by UPLC-MS/MS. The Scientific World Journal, 2014, 1-12. https://doi.org/10.1155/2014/482693
Muchakayala, S. K., Katari, N. K., Dongala, T., Marisetti, V. M., Vyas, G., & Vegesna, R. V. (2021). Eco-friendly and green chromatographic method for the simultaneous determination of chlorocresol and betamethasone dipropionate in topical formulations using Box-Behnken design. Journal of the Iranian Chemical Society, 5, 1397-1412. https://doi.org/10.1007/s13738-021-02388-5
Muchakayala, S. K., Katari, N. K., Saripella, K. K., Schaaf, H., Marisetti, V. M., Kowtharapu, L. P., & Jonnalagadda, S. B. (2022). AQbD based green UPLC method to determine mycophenolate mofetil impurities and identification of degradation products by QToF LCMS. Scientific Reports, 12, 19138. https://doi.org/10.1038/s41598-022-22998-0
Naresh, K., & Madhuri, G. V. (2014). Stability indicating method of carbidopa and levodopa assay in carbidopa, levodopa and entacapone film coated tablets by RP-HPLC. International Journal of Pharmaceutical Sciences and Research, 5(12), 5530-5538. https://doi.org/10.13040/IJPSR.0975-8232.5
Nathi, R., Kowtharapu, L. P., Muchakayala, S. K., & Konduru, N. (2023). QBD-based stability indicating liquid chromatography (RP-HPLC) method for the determination of Flurbiprofen in cataplasm. Biomedical Chromatography, 37, e5580. https://doi.org/10.1002/bmc.5580
Pappula, N., & Naresh, N. (2022). Development and validation of new UPLC method for the simultaneous estimation of Darunavir, Dolutegravir and ritonavir in combined tablet dosage form. Asian Journal of Pharmaceutical and Health Sciences, 12, 2624-2628. https://doi.org/10.5530/ajphs.2022.12.03
Patel, A., Patel, A., & Makwana, A. (2013). An ESI-LC-MS/MS method for simultaneous estimation of Darunavir and ritonavir in human plasma. International Journal of Pharma and Bio Sciences, 4, 1138-1147.
Paul, K., BH, J. G., Shankar, S. J., & Reddy, D. N. (2021). Development and validation of simplified RP-HPLC method for quantification of Darunavir in commercial tablets. Materials Today Proceedings, 47, 4155-4161. https://doi.org/10.1016/j.matpr.2021.04.444
Raju, P., Thejomoorthy, K., & Prasanna, P. S. (2021). Development and validation of new analytical method for the simultaneous estimation of Darunavir and ritonavir in pharmaceutical dosage form. International Journal of Indigenous Herbs and Drugs, 6, 49-57. https://doi.org/10.46956/ijihd.vi.157
Reddy Saddala, M. P., Konduru, N., Gundla, R., & Kowtharapu, L. P. (2022). Development and validation of novel RP-HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC-MS. Biomedical Chromatography, 36, e5486. https://doi.org/10.1002/bmc.5486
Rezk, N. L., White, N. R., Jennings, S. H., & Kashuba, A. D. (2009). A novel LCESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma. Talanta, 79, 1372-1378. https://doi.org/10.1016/j.talanta.2009.06.005
Sabyasachi, B., Sumanta, M., & Prasenjit, M. (2021). A novel ultra performance liquid chromatography-PDA method development and validation for Darunavir in Bulkand its application to marketed dosage form. Journal of Pharmacy & Bioallied Sciences, 13, 69-75. https://doi.org/10.4103/jpbs.JPBS_337_19
Satyanarayana, L., Naidu, S. V., Rao, M. N., Kumar, A., & Suresh, K. (2011). The estimation of darunavir in tablet dosage form by RP-HPLC. Asian Journal of Research in Pharmaceutical Sciences, 3, 74-76.
United States Pharmacopeia (USP) 43 National Formulary (NF) 38 General Chapters: <1225>. (2020a). Validation of compendial procedure. United States Pharmacopeial Convention.
United States Pharmacopeia (USP) 43 National Formulary (NF) 38 General Chapters: <621>. (2020b). chromatography. United States Pharmacopeial Convention.
Vemuri, D. K., Akshinthala, P., Konduru, N., Kowtharapu, L. P., Katari, N. K., Jonnalagadda, S. B., & Gundla, R. (2022). Unique quality by design approach for developing HPLC and LC-MS method for estimation of process and degradation impurities in Pibrentasvir, Antiviral Agent for Hepatitis C (Vol. 7, pp. 47650-47661). ACS omega. https://doi.org/10.1021/acsomega.2c04617